←Back to Expert Scholars
Translational Medicine / 转化医学Rare Adult Tumors, Sarcomas
William Tap
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Chief, Sarcoma Medical Oncology Service
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
William Tap chairs the MSKCC sarcoma program and led the pivotal ENLIVEN trial of pexidartinib for tenosynovial giant cell tumor. He has directed multiple phase 3 trials in advanced soft tissue sarcoma and rare mesenchymal tumors. He is a leader in ultra-rare sarcoma clinical research.
Share:
🧪Research Fields 研究领域
soft tissue sarcoma
olaratumab
pexidartinib TGCT
liposarcoma
leiomyosarcoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 William Tap 的研究动态
Follow William Tap's research updates
留下邮箱，当我们发布与 William Tap（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment